Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1990 May;49(5):276–280. doi: 10.1136/ard.49.5.276

Osteoporosis and arthritis.

J Dequeker 1, P Geusens 1
PMCID: PMC1004063  PMID: 2188623

Full text

PDF
278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Als O. S., Gotfredsen A., Christiansen C. The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state. Arthritis Rheum. 1985 Apr;28(4):369–375. doi: 10.1002/art.1780280403. [DOI] [PubMed] [Google Scholar]
  2. Canalis E., McCarthy T., Centrella M. Growth factors and the regulation of bone remodeling. J Clin Invest. 1988 Feb;81(2):277–281. doi: 10.1172/JCI113318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chesnut C. H., 3rd, Ivey J. L., Gruber H. E., Matthews M., Nelp W. B., Sisom K., Baylink D. J. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism. 1983 Jun;32(6):571–580. doi: 10.1016/0026-0495(83)90027-6. [DOI] [PubMed] [Google Scholar]
  4. Christiansen C., Riis B. J., Rødbro P. Prediction of rapid bone loss in postmenopausal women. Lancet. 1987 May 16;1(8542):1105–1108. doi: 10.1016/s0140-6736(87)91671-0. [DOI] [PubMed] [Google Scholar]
  5. Dequeker J. The relationship between osteoporosis and osteoarthritis. Clin Rheum Dis. 1985 Aug;11(2):271–296. [PubMed] [Google Scholar]
  6. Dykman T. R., Haralson K. M., Gluck O. S., Murphy W. A., Teitelbaum S. L., Hahn T. J., Hahn B. H. Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1984 Dec;27(12):1336–1343. doi: 10.1002/art.1780271203. [DOI] [PubMed] [Google Scholar]
  7. Frumar A. M., Meldrum D. R., Geola F., Shamonki I. M., Tataryn I. V., Deftos L. J., Judd H. L. Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. J Clin Endocrinol Metab. 1980 Jan;50(1):70–75. doi: 10.1210/jcem-50-1-70. [DOI] [PubMed] [Google Scholar]
  8. Geusens P., Dequeker J. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study. Bone Miner. 1986 Sep;1(4):347–357. [PubMed] [Google Scholar]
  9. Gevers G., Devos P., De Roo M., Dequeker J. Increased levels of osteocalcin (serum bone Gla-protein) in rheumatoid arthritis. Br J Rheumatol. 1986 Aug;25(3):260–262. doi: 10.1093/rheumatology/25.3.260. [DOI] [PubMed] [Google Scholar]
  10. Gundberg C. M., Markowitz M. E., Mizruchi M., Rosen J. F. Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab. 1985 Apr;60(4):736–739. doi: 10.1210/jcem-60-4-736. [DOI] [PubMed] [Google Scholar]
  11. Hajiroussou V. J., Webley M. Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. Ann Rheum Dis. 1984 Feb;43(1):24–27. doi: 10.1136/ard.43.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kaplan A. P. Kinins and bone resorption in rheumatic disease. Arthritis Rheum. 1987 May;30(5):589–592. doi: 10.1002/art.1780300517. [DOI] [PubMed] [Google Scholar]
  13. Mbuyi-Muamba J. M., Dequeker J., Gevers G. Biochemistry of bone. Baillieres Clin Rheumatol. 1988 Apr;2(1):63–101. doi: 10.1016/s0950-3579(88)80005-0. [DOI] [PubMed] [Google Scholar]
  14. Mbuyi J. M., Dequeker J., Teblick M., Merlevede M. Relevance of urinary excretion of alcian blue-glycosaminoglycans complexes and hydroxyproline to disease activity in rheumatoid arthritis. J Rheumatol. 1982 Jul-Aug;9(4):579–583. [PubMed] [Google Scholar]
  15. Mellish R. W., O'Sullivan M. M., Garrahan N. J., Compston J. E. Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis. Ann Rheum Dis. 1987 Nov;46(11):830–836. doi: 10.1136/ard.46.11.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nagant de Deuxchaisnes C., Devogelaer J. P., Huaux J. P., Esselinckx W. Influence of the menopausal state on the effect of low-dose glucocorticoid on bone mass in rheumatoid arthritis patients. Arthritis Rheum. 1986 May;29(5):693–695. doi: 10.1002/art.1780290517. [DOI] [PubMed] [Google Scholar]
  17. Rajapakse C., Thompson R., Grennan D. M., Winston B. M., Patel P., Nuttall P. M., Murphy J., Weiss J. B. Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate. Ann Rheum Dis. 1983 Apr;42(2):138–141. doi: 10.1136/ard.42.2.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Saville P. D., Kharmosh O. Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum. 1967 Oct;10(5):423–430. doi: 10.1002/art.1780100504. [DOI] [PubMed] [Google Scholar]
  19. Verstraeten A., Dequeker J. Mineral metabolism in postmenopausal women with active rheumatoid arthritis. J Rheumatol. 1986 Feb;13(1):43–46. [PubMed] [Google Scholar]
  20. Verstraeten A., Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis. 1986 Oct;45(10):852–857. doi: 10.1136/ard.45.10.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zerwekh J. E., Emkey R. D., Harris E. D., Jr Low-dose prednisone therapy in rheumatoid arthritis: effect on vitamin D metabolism. Arthritis Rheum. 1984 Sep;27(9):1050–1052. doi: 10.1002/art.1780270913. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES